NEW ON THE MARKET
Fat business: GLP-1 agonist semaglutide (WEGOVY) for weight reduction
THERAPY FROM A CRITICAL VIEWPOINT
Dual antiplatelet therapy or thrombolysis for “minor” stroke
IN BRIEF
New flu vaccines for the 2023-2024 season
SULTANOL/VENTOLINE: drugs with rebate contracts without German package leaflet
Misinformation on and overdose with food supplements
Once again: misleading advertising for desvenlafaxine (DESVENEURAX) and NEUREXAN
SIDE EFFECTS
Migraine: hair loss with CGRP antibodies
Increased risk of aspiration in patients treated with GLP-1 agonists? free article
e a-t ON THE INTERNET
„Krebs-Scan“ [a cancer screening] insurance by HanseMerkur: insurer promotes “charlatanry”